MA52793A - Agent antitumoral et méthode de traitement d'une tumeur - Google Patents

Agent antitumoral et méthode de traitement d'une tumeur

Info

Publication number
MA52793A
MA52793A MA052793A MA52793A MA52793A MA 52793 A MA52793 A MA 52793A MA 052793 A MA052793 A MA 052793A MA 52793 A MA52793 A MA 52793A MA 52793 A MA52793 A MA 52793A
Authority
MA
Morocco
Prior art keywords
tumor
treatment method
agent
tumor treatment
tumor agent
Prior art date
Application number
MA052793A
Other languages
English (en)
Inventor
Hiroshi Hirai
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of MA52793A publication Critical patent/MA52793A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MA052793A 2018-05-29 2019-05-28 Agent antitumoral et méthode de traitement d'une tumeur MA52793A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862677379P 2018-05-29 2018-05-29

Publications (1)

Publication Number Publication Date
MA52793A true MA52793A (fr) 2021-04-14

Family

ID=68698132

Family Applications (1)

Application Number Title Priority Date Filing Date
MA052793A MA52793A (fr) 2018-05-29 2019-05-28 Agent antitumoral et méthode de traitement d'une tumeur

Country Status (6)

Country Link
US (1) US20210236475A1 (fr)
EP (1) EP3804721A4 (fr)
JP (1) JP7227968B2 (fr)
MA (1) MA52793A (fr)
TW (1) TWI813694B (fr)
WO (1) WO2019230679A1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI485146B (zh) * 2012-02-29 2015-05-21 Taiho Pharmaceutical Co Ltd Novel piperidine compounds or salts thereof
US9012475B2 (en) 2013-08-27 2015-04-21 Taiho Pharmaceutical Co., Ltd. Method for enhancing anti-tumor effect of a microtubule-targeting drug, and a method for treatment of tumor
TWI693218B (zh) * 2014-11-14 2020-05-11 美商美國禮來大藥廠 極光ａ激酶抑制劑
JP6937322B2 (ja) 2016-12-22 2021-09-22 大鵬薬品工業株式会社 置換ピペリジン化合物の塩

Also Published As

Publication number Publication date
WO2019230679A1 (fr) 2019-12-05
US20210236475A1 (en) 2021-08-05
TWI813694B (zh) 2023-09-01
TW202015680A (zh) 2020-05-01
JPWO2019230679A1 (ja) 2021-05-20
EP3804721A1 (fr) 2021-04-14
JP7227968B2 (ja) 2023-02-22
EP3804721A4 (fr) 2022-03-16

Similar Documents

Publication Publication Date Title
IL280707A (en) Diagnostic and therapeutic methods for treating breast cancer
MX2018011114A (es) Métodos y composiciones relacionadas con crispr/cas para el tratamiento de beta hemoglobinopatías.
MA47310A (fr) Combinaisons de cabozantinib et d'atzolizumab pour traiter le cancer
MX2019007648A (es) Composiciones y metodos para la induccion de celulas t cd8+.
MA56212A (fr) Compositions et méthodes de traitement du cancer
MX2020001774A (es) Composiciones y métodos para tratar enfermedad colestásica.
MA43807A (fr) Préparation et composition de traitement de tumeurs malignes
BR112019002331A2 (pt) anticorpos anti-siglec-7 para o tratamento do câncer e métodos para obtenção dos mesmos
MX2020005567A (es) Metodos de tratamiento con asparaginasa.
MA47613A (fr) Compositions et procédés de traitement du cancer
MA49059A (fr) Traitement des cancers positifs à her2
MA55143A (fr) Composés aryl-aniline et hétéroaryl-aniline pour le traitement de cancers de la peau
SG11202010793UA (en) Methods of treating cancer
MA52627A (fr) Traitement du cancer
MA51678A (fr) Méthodes de traitement de l'amyotrophie musculaire
IL279591A (en) Cancer treatment methods using combination therapy
IL276203A (en) Compounds and methods for treating cancer
MA51295A (fr) Dosage, procédé et traitement d'alpha-synucléinopathies
IL281600A (en) Methods of treating cancer
EA201991927A1 (ru) Новый иммуностимулирующий макролид
IL277981A (en) Cancer treatment methods
MX2023007680A (es) Metodos de tratamiento y terapia de mantenimiento para el cancer de vejiga con gemcitabina.
MA55093A (fr) Méthodes et compositions pour le traitement du cancer
MA52793A (fr) Agent antitumoral et méthode de traitement d'une tumeur
GB201820994D0 (en) Methods of treatment and diagnosis of tumours